Login / Signup

Dectin-2 Deficiency Promotes Pro-inflammatory Cytokine Release from Macrophages and Impairs Insulin Secretion.

Masamichi FujitaTakashi MiyazawaKeiichiro UchidaNaohiro UchidaShojiro HajiSeiichi YanoNorifusa IwahashiTomomi HatayamaShunsuke KatsuharaShintaro NakamuraYukina TakeichiMaki Yokomoto-UmakoshiYasutaka MiyachiRyuichi SakamotoYoichiro IwakuraYoshihiro Ogawa
Published in: Endocrinology (2023)
Pancreatic islet inflammation plays a crucial role in the etiology of type 2 diabetes (T2D). Macrophages residing in pancreatic islets have emerged as key players in islet inflammation. Macrophages express a plethora of innate immune receptors that bind to environmental and metabolic cues and integrate these signals to trigger an inflammatory response that contributes to the development of islet inflammation. One such receptor, Dectin-2, has been identified within pancreatic islets; however, its role in glucose metabolism remains largely unknown. Here we demonstrated that mice lacking Dectin-2 exhibit local inflammation within islets, along with impaired insulin secretion and β-cell dysfunction. Our findings indicate that these effects are mediated by pro-inflammatory cytokines, such as IL-1α and IL-6, which are secreted by macrophages that have acquired an inflammatory phenotype because of the loss of Dectin-2. This study provides novel insights into the mechanisms underlying the role of Dectin-2 in the development of islet inflammation.
Keyphrases
  • oxidative stress
  • inflammatory response
  • innate immune
  • stem cells
  • cell therapy
  • single cell
  • mesenchymal stem cells
  • anti inflammatory